Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season

Clinical Infectious Diseases

Volumn 69, Issue 11, 2019, Pages 1845-1853

  Rolfes, Melissa A ^a   Flannery, Brendan ^a   Chung, Jessie R ^a   O'Halloran, Alissa ^a   Garg, Shikha ^a   Belongia, Edward A ^b   Gaglani, Manjusha ^c   Zimmerman, Richard K ^d   Jackson, Michael L ^e   Monto, Arnold S ^f   Alden, Nisha B ^g   Anderson, Evan ^h   Bennett, Nancy M ⁱ   Billing, Laurie ^j   Eckel, Seth ^k   Kirley, Pam Daily ^l   Lynfield, Ruth ^m   Monroe, Maya L ⁿ   Spencer, Melanie ^o   Spina, Nancy ^p   Talbot, H Keipp ^q   Thomas, Ann ^r   Torres, Salina M ^s   Yousey Hindes, Kimberly ^t   Singleton, James A ^a   Patel, Manish ^a   Reed, Carrie ^a   Fry, Alicia M ^a   McLean, Huong Q ^u   King, Jennifer P ^u   Nowalk, Mary Patricia ^u   Balasubramani, G K ^u   Bear, Todd M ^u   Hickey, Robert ^u   Williams, John V ^u   Reis, Evelyn C ^u   Moehling, Krissy K ^u   Eng, Heather ^u   Jackson, Lisa A ^u   Smith, Michael ^u   Raiyani, Chandni ^u   Clipper, Lydia ^u   Murthy, Kempapura ^u   Chen, Wencong ^u   Reis, Michael ^u   Petrie, Joshua G ^u   Malosh, Ryan E ^u   McSpadden, E J ^u   Segaloff, Hannah E ^u   Cheng, Caroline K ^u   Truscon, Rachel ^u   Johnson, Emileigh ^u   Lamerato, Lois E ^u   Rosenblum, Bret ^u   Ford, Samantha ^u   Johnson, Monika ^u   Raviotta, Jonathan M ^u   Sax, Terrie ^u   Steele, Jonathan ^u   Susick, Michael ^u   Chabra, Rina ^u   Garofolo, Edward ^u   Iozzi, Philip ^u   Kevish, Barbara ^u   Middleton, Donald B ^u   Urbanski, Leonard ^u   Ponder, Teresa ^u   Crumbaker, Todd ^u   Iosefo, Iosefo ^u   Sleeth, Patricia ^u   Gandy, Virginia ^u   Bounds, Kelsey ^u   Kylberg, Mary ^u   Rao, Arundhati ^u   Fader, Robert ^u   Walker, Kimberley ^u   Volz, Marcus ^u   Ray, Jeremy ^u   Price, Deborah ^u   Thomas, Jennifer ^u   Wehbe Janek, Hania ^u   Beeram, Madhava ^u   Boyd, John ^u   Walkowiak, Jamie ^u   Probe, Robert ^u   Couchman, Glen ^u   Motakef, Shahin ^u   Arroliga, Alejandro ^u   Kaniclides, Anne ^u   Bouldin, Emerson ^u   Baker, Christoph ^u   Berke, Kimberly ^u   Smith, Mackenzie ^u   Rajesh, Niharika ^u   Alleman, Elizabeth ^u   Bauer, Sarah ^u   Groesbeck, Michelle ^u   Brundidge, Kristyn ^u   Hafeez, Neha ^u   Jackson, Jayla ^u   Anastasia, Ian ^u   Kadoo, Gabriel ^u   Petnic, Sarah ^u   Ryan, Alison ^u   Maslar, Amber ^u   Meek, James ^u   Chen, Rona ^u   Stephens, Samantha ^u   Thomas, Stepy ^u   Segler, Suzanne ^u   Openo, Kyle ^u   Fawcett, Emily ^u   Farley, Monica ^u   Martin, Andrew ^u   Ryan, Patricia ^u   Sunkel, Robert ^u   Lutich, Taylor ^u   Perlmutter, Rebecca ^u   Grace, Brittany ^u   Blood, Timothy ^u   Zerrlaut, Cindy ^u   McMahon, Melissa ^u   Strain, Anna ^u   Christensen, Jamie ^u   Angeles, Kathy ^u   Butler, Lisa ^u   Khanlian, Sarah ^u   Mansmann, Robert ^u   McMullen, Chelsea ^u   Pradhan, Eva ^u   Manzi, Katarina ^u   Felsen, Christina ^u   Gaitan, Maria ^u   Long, Krista ^u   Fisher, Nicholas ^u   Hawley, Emily ^u   O'Shaughnessy, Rory ^u   Scott, Magdalena ^u   Crawford, Courtney ^u   Schaffner, William ^u   Markus, Tiffanie ^u   Leib, Karen ^u   Dyer, Katie ^u   Santibanez, Tammy ^u   Zhai, Yusheng ^u   Lu, Pengjun ^u   Srivastav, Anup ^u   Hung, Mei Chuan ^u   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MARSHFIELD CLINIC   (United States)

^c TEXAS A M COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e KAISER PERMANENTE   (United States)

^f UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^g Colorado Department of Public Health and Environment ^*  (United States)

^h EMORY UNIVERSITY   (United States)

ⁱ UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^j OHIO DEPARTMENT OF HEALTH   (United States)

^k MICHIGAN DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^l CALIFORNIA EMERGING INFECTIONS PROGRAM   (United States)

^m MINNESOTA DEPARTMENT OF HEALTH   (United States)

ⁿ Maryland Department of Mental Health   (United States)

^o Salt Lake City Fire Department (SLCFD)   (United States)

^p NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^q VANDERBILT UNIVERSITY   (United States)

^r OREGON PUBLIC HEALTH DIVISION   (United States)

^s NEW MEXICO DEPARTMENT OF HEALTH   (United States)

^t YALE UNIVERSITY   (United States)

^u NONE

more..

Author keywords

burden; influenza; prevented illnesses; vaccination

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; COMPARTMENT MODEL; DEATH; FEMALE; HOSPITALIZATION; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OUTPATIENT; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNITED STATES; YOUNG ADULT; INFANT; INFLUENZA; VACCINATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 85065791740     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciz075     Document Type: Article

References (50)

1. Biggerstaff M, Kniss K, Jernigan DB, et al. Systematic assessment of multiple routine and near-real time indicators to classify the severity of influenza seasons and pandemics in the United States, 2003-04 through 2015-2016. Am J Epidemiol 2018; 187:1040-50.
2. Garten R, Blanton L, Elal AIA, et al. Update: influenza activity in the United states during the 2017-18 season and composition of the 2018-19 influenza Vaccine. MMWR Morb Mortal Wkly Rep 2018; 67:634-42.
3. Centers for Disease Control and Prevention. Estimated influenza illnesses, medical visits, hospitalizations, and deaths in the United States-2017-2018 influenza season. Available at: https://www. cdc. gov/flu/about/burden/estimates. htm. Accessed 29 October 2018.
4. Centers for Disease Control and Prevention. Estimates of influenza vaccination coverage and adults-United States, 2017-18 flu season. Available at: https:// www. cdc. gov/flu/fluvaxview/coverage-1718estimates. htm. Accessed 29 October 2018.
5. Centers for Disease Control and Prevention. Estimates of flu vaccination coverage among children-United States, 2017-18 flu season. Available at: https:// www. cdc. gov/flu/fluvaxview/coverage-1718estimates-children. htm. Accessed 29 October 2018.
6. Flannery B, Chung JR, Belongia EA, et al. Interim estimates of 2017-18 seasonal influenza vaccine effectiveness-United States, February 2018. MMWR Morb Mortal Wkly Rep 2018; 67:180-5.
7. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices-United States, 2017-18 influenza season. MMWR Recomm Rep 2017; 66:1-20.
8. Gaglani M, Pruszynski J, Murthy K, et al. Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013-2014 in the United States. J Infect Dis 2016; 213:1546-56.
9. McLean HQ, Thompson MG, Sundaram ME, et al. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis 2015; 211:1529-40.
10. Ohmit SE, Petrie JG, Malosh RE, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 2013; 56:1363-9.
11. Zimmerman RK, Nowalk MP, Chung J, et al. 2014-2015 influenza vaccine effectiveness in the United States by vaccine type. Clin Infect Dis 2016; 63:1564-73.
12. Jackson ML, Chung JR, Jackson LA, et al. Influenza vaccine effectiveness in the United States during the 2015-2016 season. N Engl J Med 2017; 377:534-43.
13. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 2016; 65:1-54.
14. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 31:2165-8.
15. Reed C, Chaves SS, Daily Kirley P, et al. Estimating influenza disease burden from population-based surveillance data in the United States. PLoS One 2015; 10:e0118369.
16. Chaves SS, Lynfield R, Lindegren ML, Bresee J, Finelli L. The US influenza hospitalization surveillance network. Emerg Infect Dis 2015; 21:1543-50.
17. Tokars JI, Rolfes MA, Foppa IM, Reed C. An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States. Vaccine 2018; 36:7331-7.
18. Reed C, Angulo FJ, Swerdlow DL, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis 2009; 15:2004-7.
19. Rolfes MA, Foppa IM, Garg S, et al. Annual estimates of the burden of seasonal influenza in the United States: a tool for strengthening influenza surveillance and preparedness. Influenza Other Respir Viruses 2018; 12:132-7.
20. Flannery B, Chung J, Ferdinands J. Preliminary estimates of 2017-18 seasonal influenza vaccine effectiveness against laboratory-confirmed influenza from the US Flu VE and HAIVEN Networks. In: Advisory Committee on Immunization Practices; Atlanta, GA, 2018. Available at: https://www. cdc. gov/vaccines/acip/ meetings/downloads/slides-2018-06/flu-02-Flannery-508. pdf.
21. Brown C, Clayton-Boswell H, Chaves SS, et al; New Vaccine Surveillance Network. Validity of parental report of influenza vaccination in young children seeking medical care. Vaccine 2011; 29:9488-92.
22. Mangtani P, Shah A, Roberts JA. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect 2007; 135:139-43.
23. Poehling KA, Vannoy L, Light LS, et al. Assessment of parental report for 2009-2010 seasonal and monovalent H1N1 influenza vaccines among children in the emergency department or hospital. Acad Pediatr 2012; 12:36-42.
24. Irving SA, Donahue JG, Shay DK, Ellis-Coyle TL, Belongia EA. Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine 2009; 27:6546-9.
25. King JP, McLean HQ, Belongia EA. Validation of self-reported influenza vaccination in the current and prior season. Influenza Other Respir Viruses 2018; 12:808-13.
26. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices-United States, 2017-18 influenza season. Am J Transplant 2017; 17:2970-82.
27. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000; 284:1677-82.
28. Monto AS, Davenport FM, Napier JA, Francis T Jr. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 1970; 122:16-25.
29. Pebody RG, Sinnathamby MA, Warburton F, et al. Uptake and impact of vaccinating primary school-age children against influenza: experiences of a live attenuated influenza vaccine programme, England, 2015/16. Euro Surveill 2018; 23: pii=1700496.
30. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005; 23:1540-8.
31. Rudenko LG, Slepushkin AN, Monto AS, et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis 1993; 168:881-7.
32. Loeb M, Russell ML, Moss L, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 2010; 303:943-50.
33. Mertz D, Fadel SA, Lam PP, et al. Herd effect from influenza vaccination in non-healthcare settings: a systematic review of randomised controlled trials and observational studies. Euro Surveill 2016; 21: pii=30378.
34. Arinaminpathy N, Kim IK, Gargiullo P, et al. Estimating direct and indirect protective effect of influenza vaccination in the United States. Am J Epidemiol 2017; 186:92-100.
35. Sah P, Medlock J, Fitzpatrick MC, Singer BH, Galvani AP. Optimizing the impact of low-efficacy influenza vaccines. Proc Natl Acad Sci U S A 2018; 115:5151-6.
36. Flannery B, Chung JR, Monto AS, et al. Influenza vaccine effectiveness in the United States during the 2016-2017 season. Clin Infect Dis 2018; 64:736-42.
37. DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014; 371:635-45.
38. Belongia EA, Sundaram ME, McClure DL, Meece JK, Ferdinands J, VanWormer JJ. Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. Vaccine 2015; 33:246-51.
39. Jimenez-Jorge S, de Mateo S, Delgado-Sanz C, et al. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination. BMC Infect Dis 2013; 13:441.
40. Kissling E, Valenciano M, Larrauri A, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill 2013; 18: pii=20390.
41. Pebody R, Andrews N, McMenamin J, et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill 2013; 18: pii=20389.
42. Petrie JG, Ohmit SE, Truscon R, et al. Modest waning of influenza vaccine efficacy and antibody titers during the 2007-2008 influenza season. J Infect Dis 2016; 214:1142-9.
43. Sullivan SG, Komadina N, Grant K, Jelley L, Papadakis G, Kelly H. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match. J Med Virol 2014; 86:1017-25.
44. Ferdinands JM, Fry AM, Reynolds S, et al. Intraseason waning of influenza vaccine protection: evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15. Clin Infect Dis 2017; 64:544-50.
45. Centers for Disease Control and Prevention. Interim results: state-specific seasonal influenza vaccination coverage-United States, August 2009-January 2010. MMWR Morb Mortal Wkly Rep 2010; 59:477-84.
46. Zimmerman RK, Raymund M, Janosky JE, Nowalk MP, Fine MJ. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 2003; 21:1486-91.
47. Fry AM, Kim IK, Reed C, et al. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults. Clin Infect Dis 2014; 59:406-9.
48. Dunkle LM, Izikson R, Patriarca P, et al; PSC12 Study Team. Efficacy of recombinant influenza vaccine in adults 50 years of age or older. N Engl J Med 2017; 376:2427-36.
49. Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 influenza season. MMWR Recomm Rep 2018; 67:1-20.
50. Barr IG, Donis RO, Katz JM, et al. Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness. NPJ Vaccines 2018; 3:44; doi:10. 1038/s41541-018-0079-z